Skip to main content
Clinical Trials/NCT06037707
NCT06037707CompletedNot Applicable

Incidence of Thromboembolism in COVID-19 Infection in the ICU: a Retrospective Cohort Analysis

Ayse Zeynep Turan1 site in 1 country484 target enrollmentStarted: January 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
484
Locations
1
Primary Endpoint
Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease

Study Overview

Brief Summary

The present study aims to determine frequency of thromboembolic complications and the underlying causes of this complication of the patients who admitted to the intensive care unit diagnosed with COVID-19.

Detailed Description

Patients diagnosed with COVID-19 infection and admitted to the ICU were recruited. Demographic information, comorbidities, length of ICU stay, some laboratory data,thromboembolic complications of the patients were recorded.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients who were infected with COVID-19 and admitted to the intensive care unit between the time of March 2020-December 2021

Exclusion Criteria

  • who is under 18 years old.

Outcomes

Primary Outcomes

Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease

Time Frame: During the entire intensive care stay up to 1 day

Both arterial and venous thromboembolic events were detected

Secondary Outcomes

  • Rate of thromboembolic complications of COVID-19 disease in critically ill patients(During the entire intensive care stay up to 1 day)
  • What is the rate of thromboembolism according to the comorbidities(During the entire intensive care stay up to 1 day)
  • Rate of thromboembolic complications according to anticoagulant therapy(During the entire intensive care stay up to 1 day)

Investigators

Sponsor
Ayse Zeynep Turan
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Ayse Zeynep Turan

Principle Investigator

Derince Training and Research Hospital

Study Sites (1)

Loading locations...

Similar Trials